Data suggest that SC pembrolizumab is non-inferior to IV pembrolizumab in patients with newly diagnosed, advanced NSCLC.

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

Merck’s pembrolizumab with berahyaluronidase alfa demonstrates noninferior PK compared to IV Keytruda in pivotal 3475A-D77 trial: Rahway, New Jersey Saturday, March 29, 2025, 10 ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

A leaked plan from EPA Administrator Zeldin to do away with the agency’s research office caught many by surprise. What does the EPA's science arm do in Houston?

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

An IV was inserted into Gunches’ right arm without issue. A second IV took more time to be ... Navajo Code Talker links restored on DOD sites; other Native stories still missing Arizona promises ...

The CRN property is approximately 1,200 acres of land located on the northern bank of the Clinch River arm of ... for the CRN ...

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ...

Which baseball team will continue the Berkshire County run of MIAA Final Four teams? A look at all the teams in Berkshire ...

The judge allowed a negligence claim to proceed to trial but threw out allegations that officers discriminated against the ...